Johnson & Johnson JNJ

NYSE US Health Care Pharmaceuticals

$256.35 ▲ +0.21% (+$0.53)

Index member: S&P 500 Dow Jones

Open $256.01

Prev Close $255.82

Day Range $253.29 – $258.48

52W Range $164.23 – $274.90

Market Cap $617.78B

P/E (TTM) 29.53

Beta 0.23

Div Yield 2.10%

EPS (TTM) $8.62

📋 Company Profile

Industry	Pharmaceuticals
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1944-09-25
Shares Out.	2,409,900,000
Website	jnj.com/ ↗
Phone	17325242455
Employees	140,800
Revenue	$25.31B
Gross Profit	$17.26B
Net Income	$5.53B
Free Cash Flow	$22.23B
Total Assets	$201.06B
Total Liabilities	$116.09B
Equity	$84.97B

About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson is a publicly traded company under the ticker symbol JNJ on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.